Literature DB >> 34255312

Role of ARID1A in the Regulation of Human Trophoblast Migration and Invasion.

Meiyuan Jin1, Shouying Xu2, Jiayong Li3, Lu Li4, Chao Tang5.   

Abstract

Migration and invasion of trophoblasts is critical for human placental development, trophoblastic differentiation, and pregnancy-associated diseases. AT-rich interactive domain-containing protein 1A (ARID1A), a subunit of the SWI-SNF complex, has been suggested to participate in the regulation of fertility via placental disruption in mice. However, whether ARID1A regulates human placental development and function remains unknown. Here, using human trophoblast-like JEG-3 cell line, we report that ARID1A controls trophoblast cell migration and invasion. Overexpression of ARID1A inhibits JEG-3 cell migration and invasion, whereas knockdown of ARID1A promotes migration and invasion in JEG-3 cells. Mechanistically, while ARID1A reduces JEG-3 cell migration by down-regulation of Snail transcription, it restrains JEG-3 cell invasion by binding to and destabilization of MMP-9 protein. Finally, ARID1A is apparently up-regulated in placental tissues of preeclampsia compared to that of normal pregnancies. Our results thereby imply that ARID1A acts as a critical gene in supporting the physiological function of human mature placenta.
© 2021. Society for Reproductive Investigation.

Entities:  

Keywords:  ARID1A; Invasion; Migration; Trophoblast

Mesh:

Substances:

Year:  2021        PMID: 34255312     DOI: 10.1007/s43032-021-00686-0

Source DB:  PubMed          Journal:  Reprod Sci        ISSN: 1933-7191            Impact factor:   2.924


  50 in total

Review 1.  Cadherins in the human placenta--epithelial-mesenchymal transition (EMT) and placental development.

Authors:  M I Kokkinos; P Murthi; R Wafai; E W Thompson; D F Newgreen
Journal:  Placenta       Date:  2010-07-24       Impact factor: 3.481

Review 2.  Latest advances in understanding preeclampsia.

Authors:  Christopher W Redman; Ian L Sargent
Journal:  Science       Date:  2005-06-10       Impact factor: 47.728

3.  Late sporadic miscarriage is associated with abnormalities in spiral artery transformation and trophoblast invasion.

Authors:  E Ball; J N Bulmer; S Ayis; F Lyall; S C Robson
Journal:  J Pathol       Date:  2006-03       Impact factor: 7.996

Review 4.  The uterine spiral arteries in human pregnancy: facts and controversies.

Authors:  R Pijnenborg; L Vercruysse; M Hanssens
Journal:  Placenta       Date:  2006-02-20       Impact factor: 3.481

Review 5.  The pathology of placenta accreta, a worldwide epidemic.

Authors:  T Y Khong
Journal:  J Clin Pathol       Date:  2008-07-19       Impact factor: 3.411

Review 6.  Differential expression of growth-, angiogenesis- and invasion-related factors in the development of placenta accreta.

Authors:  Jenn-Jhy Tseng; Min-Min Chou
Journal:  Taiwan J Obstet Gynecol       Date:  2006-06       Impact factor: 1.705

7.  Establishment of maternal blood supply to the placenta: insights into plugging, unplugging and trophoblast behaviour from an agent-based model.

Authors:  Rojan Saghian; Gib Bogle; Joanna L James; Alys R Clark
Journal:  Interface Focus       Date:  2019-08-16       Impact factor: 3.906

Review 8.  A lesson for cancer research: placental microarray gene analysis in preeclampsia.

Authors:  Frank Louwen; Cornelia Muschol-Steinmetz; Joscha Reinhard; Anke Reitter; Juping Yuan
Journal:  Oncotarget       Date:  2012-08

9.  Early-Stage Induction of SWI/SNF Mutations during Esophageal Squamous Cell Carcinogenesis.

Authors:  Hidetsugu Nakazato; Hideyuki Takeshima; Takayoshi Kishino; Emi Kubo; Naoko Hattori; Takeshi Nakajima; Satoshi Yamashita; Hiroyasu Igaki; Yuji Tachimori; Yukio Kuniyoshi; Toshikazu Ushijima
Journal:  PLoS One       Date:  2016-01-26       Impact factor: 3.240

View more
  1 in total

1.  Hedgehog signaling is controlled by Rac1 activity.

Authors:  Chao Tang; Ximei Wu; Qianlei Ren; Minli Yao; Shouying Xu; Ziyi Yan
Journal:  Theranostics       Date:  2022-01-01       Impact factor: 11.556

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.